| 產品名稱 |
Influenza B virus |
| 商品貨號 |
B187002 |
| Classification |
Orthomyxoviridae, Influenzavirus B |
| Agent |
Influenza B virus |
| Strain |
B/R75 |
| Applications |
Influenza Research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
derived from a cross of existing strains |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder
(or colder) |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Effect on Host |
Yes, in vitro effects: hemagglutination of chicken red blood cells hemagglutination of chicken RBCs |
| Recommended Host |
Recommended Host:? SPF CE (10 to 11 day, i.a.) |
| Growth Conditions |
Temperature: 37.0°C Duration: 1-4 days |
| Cryopreservation |
Storage temperature: -70°C |
| Name of Depositor |
R.I.T. - Recherche et Industrie Therapeutiques |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
derived from a cross of existing strains |
| References |
or colder
10 to 11-day specific pathogen free (SPF) intra allantoic inoculation
recombinant of influenza type B Hong Kong/5/72 [from human with influenza] and type B/Brigit
or colder
|
